Centene Corporation is a healthcare company. The Company provides a portfolio of services to government sponsored healthcare programs, focusing on under-insured and uninsured individuals. The Company operates through two segments: Managed Care and Specialty Services. The Company's Managed Care segment provides health plan coverage to individuals, through government subsidized programs, including Medicaid, the State Children's Health Insurance Program (CHIP), Long Term Care, Foster Care, dual-eligible individuals (Duals) and the Supplemental Security Income Program, also known as the Aged, Blind or Disabled Program (ABD), Medicare, and Health Insurance Marketplace. Its Specialty Services segment consists of its specialty companies offering a range of healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups and other commercial organizations, as well as to its own subsidiaries.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Managed Health Care
- Sub-Industry: Managed Health Care
- Symbol: NYSE:CNC
- CUSIP: 15135B10
- Web: www.centene.com
Capitalization:- Market Cap: $15.65 billion
- Outstanding Shares: 172,475,000
Average Prices:- 50 Day Moving Avg: $86.60
- 200 Day Moving Avg: $78.42
- 52 Week Range: $50.00 - $98.72
P/E:- Trailing P/E Ratio: 19.91
- Foreward P/E Ratio: 16.62
- P/E Growth: 1.50
Sales & Book Value:- Annual Revenue: $43.65 billion
- Price / Sales: 0.36
- Book Value: $36.98 per share
- Price / Book: 2.45
Profitability:- EBIDTA: $2.19 billion
- Net Margins: 1.72%
- Return on Equity: 14.62%
- Return on Assets: 4.24%
Debt:- Debt-to-Equity Ratio: 0.74%
- Current Ratio: 1.08%
- Quick Ratio: 1.08%
Misc:- Average Volume: 1.50 million shs.
- Beta: 0.63
- Short Ratio: 1.82
Frequently Asked Questions for Centene Corporation (NYSE:CNC)
What is Centene Corporation's stock symbol?
Centene Corporation trades on the New York Stock Exchange (NYSE) under the ticker symbol "CNC."
How were Centene Corporation's earnings last quarter?
Centene Corporation (NYSE:CNC) released its earnings results on Tuesday, July, 25th. The company reported $1.59 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $1.30 by $0.29. The firm had revenue of $11.95 billion for the quarter, compared to the consensus estimate of $11.69 billion. Centene Corporation had a return on equity of 14.62% and a net margin of 1.72%. The firm's revenue for the quarter was up 9.7% compared to the same quarter last year. During the same period in the prior year, the business posted $1.29 earnings per share. View Centene Corporation's Earnings History.
When will Centene Corporation make its next earnings announcement?
What guidance has Centene Corporation issued on next quarter's earnings?
Centene Corporation issued an update on its FY17 earnings guidance on Tuesday, July, 25th. The company provided earnings per share guidance of $4.70-5.06 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.79. The company issued revenue guidance of $46.4-47.2 billion, compared to the consensus revenue estimate of $46.82 billion.
Where is Centene Corporation's stock going? Where will Centene Corporation's stock price be in 2017?
17 brokers have issued 1-year target prices for Centene Corporation's stock. Their forecasts range from $69.00 to $111.00. On average, they expect Centene Corporation's stock price to reach $91.67 in the next year. View Analyst Ratings for Centene Corporation.
What are analysts saying about Centene Corporation stock?
Here are some recent quotes from research analysts about Centene Corporation stock:
- 1. According to Zacks Investment Research, "Year to date, Centene’s shares have outperformed the industry. The company’s strong and consistent performance is likely to have generated confidence among the investors. It has seen substantial inorganic growth in the last five years. The acquisition of Health Net in 2016 bolstered the company’s growth, expansion and asset base. Its solid financial position provides a major boost to its capital deployment initiatives. The company’s strong Managed care segment also contributes to its strong results. The stock has seen the Zacks Consensus Estimate for the current year being revised upward by 3.4% in the last 60 days." (9/15/2017)
- 2. Cantor Fitzgerald analysts commented, "This morning, CNC reported 2Q17 results. Revenue of $11.95 billion was slightly ahead of FactSet consensus. Adjusted EPS was $1.59 vs. our estimate of $1.25 and consensus of $1.30." (7/25/2017)
Who are some of Centene Corporation's key competitors?
Some companies that are related to Centene Corporation include McKesson Corporation (MCK), Fresenius Medical Care Corporation (FMS), Actelion (ALIOF), Illumina (ILMN), HCA Holdings (HCA), Essilor International SA (ESLOY), Astellas Pharma (ALPMY), Incyte Corporation (INCY), Edwards Lifesciences Corporation (EW), C.R. Bard (BCR), Cerner Corporation (CERN), Zimmer Biomet Holdings (ZBH), Cardinal Health (CAH), Quintiles Transitional Holdings (Q), Lonza Group Ag (LZAGY), Teva Pharmaceutical Industries Limited (TEVA), AmerisourceBergen Corporation (Holding Co) (ABC) and Mylan N.V. (MYL).
Who are Centene Corporation's key executives?
Centene Corporation's management team includes the folowing people:
- Michael F. Neidorff, Chairman of the Board, President, Chief Executive Officer
- Jeffrey A. Schwaneke CPA, Chief Financial Officer, Executive Vice President, Treasurer
- Keith H. Williamson, Executive Vice President, General Counsel, Secretary
- Christopher D. Bowers, Executive Vice President - Marketing
- Cynthia J. Brinkley, Executive Vice President - Global Corporate Development
- Jesse N. Hunter, Executive Vice President - Products
- Christopher R. Isaak, Senior Vice President, Corporate Controller and Chief Accounting Officer
- Mark J. Brooks, Senior Vice President, Chief Information Officer
- Christopher A. Koster, Senior Vice President - Corporate Services
- Orlando Ayala, Independent Director
Who owns Centene Corporation stock?
Centene Corporation's stock is owned by a number of of institutional and retail investors. Top institutional investors include
VANGUARD GROUP INC
(10.11%), Vanguard Group Inc. (9.70%), BlackRock Inc. (7.74%), Capital World Investors (4.42%), State Street Corp (4.15%) and Wells Fargo & Company MN (2.43%). Company insiders that own Centene Corporation stock include Carol Goldman, Christopher D Bowers, Jeffrey A Schwaneke, Jesse N Hunter, Keith H Williamson, Kenneth Rone Baldwin, Mark J Brooks, Michael F Neidorff, Richard A Gephardt and Robert K Ditmore. View Institutional Ownership Trends for Centene Corporation.
Who sold Centene Corporation stock? Who is selling Centene Corporation stock?
Centene Corporation's stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., American Century Companies Inc., Schroder Investment Management Group, Neuberger Berman Group LLC, William Blair Investment Management LLC, Korea Investment CORP, FMR LLC and BNP Paribas Arbitrage SA. Company insiders that have sold Centene Corporation stock in the last year include Carol Goldman, Christopher D Bowers, Jeffrey A Schwaneke, Jesse N Hunter, Keith H Williamson, Kenneth Rone Baldwin, Mark J Brooks, Michael F Neidorff, Richard A Gephardt and Robert K Ditmore. View Insider Buying and Selling for Centene Corporation.
Who bought Centene Corporation stock? Who is buying Centene Corporation stock?
Centene Corporation's stock was bought by a variety of institutional investors in the last quarter, including Ameriprise Financial Inc., AJO LP, Vanguard Group Inc., Numeric Investors LLC, Wedge Capital Management L L P NC, Wells Fargo & Company MN, Teachers Advisors LLC and HealthCor Management L.P.. View Insider Buying and Selling for Centene Corporation.
How do I buy Centene Corporation stock?
Shares of Centene Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Centene Corporation's stock price today?
One share of Centene Corporation stock can currently be purchased for approximately $90.74.
MarketBeat Community Rating for Centene Corporation (NYSE CNC)MarketBeat's community ratings are surveys of what our community members think about Centene Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Centene Corporation (NYSE:CNC) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 1 Sell Rating, 4 Hold Ratings, 12 Buy Ratings |
| Consensus Rating: | Buy (Score: 2.65) |
| Consensus Price Target: | $91.67 (1.02% upside) |
Analysts' Ratings History for Centene Corporation (NYSE:CNC)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 9/21/2017 | Morgan Stanley | Boost Price Target | Overweight | $94.00 -> $103.00 | Low |  |
| 9/14/2017 | Deutsche Bank AG | Reiterated Rating | Buy | $95.00 -> $111.00 | Low | |
| 9/13/2017 | Leerink Swann | Reiterated Rating | Market Perform -> Market Perform | $78.00 -> $90.00 | High | |
| 9/13/2017 | Cowen and Company | Reiterated Rating | Outperform | $77.00 -> $105.00 | High | |
| 9/13/2017 | Cantor Fitzgerald | Boost Price Target | Overweight | $107.00 | High | |
| 9/1/2017 | Piper Jaffray Companies | Reiterated Rating | Buy | $105.00 | Low | |
| 7/27/2017 | Jefferies Group LLC | Reiterated Rating | Buy | $98.00 | Low | |
| 7/26/2017 | Citigroup Inc. | Boost Price Target | Sell | $80.00 -> $89.00 | Medium | |
| 7/14/2017 | Bank of America Corporation | Boost Price Target | Buy | $93.00 -> $95.00 | Low | |
| 7/11/2017 | Sanford C. Bernstein | Reiterated Rating | Outperform | | Medium | |
| 6/19/2017 | Credit Suisse Group | Reiterated Rating | Neutral | $78.00 -> $81.00 | Low | |
| 5/22/2017 | J P Morgan Chase & Co | Downgrade | Overweight -> Neutral | $75.00 | Medium | |
| 4/26/2017 | Evercore ISI | Boost Price Target | Outperform | $80.00 -> $83.00 | High | |
| 4/26/2017 | Stifel Nicolaus | Boost Price Target | Buy | $80.00 -> $85.00 | High | |
| 2/8/2017 | Barclays PLC | Boost Price Target | Overweight | $75.00 -> $79.00 | N/A | |
| 12/20/2016 | Oppenheimer Holdings, Inc. | Reiterated Rating | Outperform | | N/A | |
| 12/13/2016 | Goldman Sachs Group, Inc. (The) | Upgrade | Sell -> Neutral | | N/A | |
| 9/7/2016 | Wedbush | Reiterated Rating | Outperform | $85.00 | N/A | |
| 9/1/2016 | FBR & Co | Reiterated Rating | Buy | | N/A | |
| 6/28/2016 | Wolfe Research | Initiated Coverage | Market Perform | $80.00 | N/A | |
| 6/20/2016 | Wells Fargo & Company | Reiterated Rating | Buy | | N/A | |
(Data available from 9/22/2015 forward)
Earnings History for Centene Corporation (NYSE:CNC)Earnings History by Quarter for Centene Corporation (NYSE CNC)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 10/24/2017 | | $1.24 | | | | | N/A | |
| 7/25/2017 | Q2 2017 | $1.30 | $1.59 | $11.69 billion | $11.95 billion | View | N/A | |
| 4/25/2017 | Q1 17 | $1.06 | $1.12 | $11.44 billion | $11.72 billion | View | N/A | |
| 2/7/2017 | Q416 | $1.11 | $1.19 | $10.94 billion | $11.91 billion | View | N/A | |
| 10/25/2016 | Q316 | $1.15 | $1.11 | $10.96 million | $10.85 billion | View | Listen | |
| 7/26/2016 | Q216 | $1.09 | $1.29 | $10.80 billion | $10.90 billion | View | Listen | |
| 4/26/2016 | Q116 | $0.74 | $0.74 | $7.88 billion | $6.95 billion | View | Listen | |
| 2/9/2016 | Q415 | $0.82 | $0.95 | $6.14 billion | $6.30 billion | View | N/A | |
| 10/27/2015 | Q315 | $0.78 | $0.84 | $5.79 billion | $5.82 billion | View | Listen | |
| 7/28/2015 | Q215 | $0.69 | $0.73 | $5.54 billion | $5.51 billion | View | Listen | |
| 4/28/2015 | Q115 | $0.48 | $0.52 | $5.12 billion | $5.13 billion | View | Listen | |
| 2/3/2015 | Q414 | $1.70 | $1.74 | $4.62 billion | $4.42 billion | View | Listen | |
| 10/28/2014 | Q314 | $0.96 | $1.22 | $4.23 billion | $4.35 billion | View | Listen | |
| 7/22/2014 | Q214 | $0.73 | $0.79 | $3.66 billion | $4.02 billion | View | Listen | |
| 4/22/2014 | Q1 | $0.44 | $0.57 | $3.25 billion | $3.35 billion | View | Listen | |
| 2/4/2014 | Q413 | $0.83 | $0.84 | $2.93 billion | $2.86 billion | View | Listen | |
| 10/22/2013 | Q313 | $0.84 | $0.87 | $2.68 billion | $2.70 billion | View | Listen | |
| 7/23/2013 | Q2 2013 | $0.62 | $0.77 | $2.63 billion | $2.73 billion | View | Listen | |
| 4/23/2013 | Q1 2013 | $0.38 | $0.42 | $2.46 billion | $2.54 billion | View | Listen | |
| 2/5/2013 | Q4 2012 | $0.32 | $0.17 | $2.40 billion | $2.30 billion | View | Listen | |
| 10/23/2012 | | $0.48 | $0.07 | | | View | N/A | |
| 7/24/2012 | | ($0.10) | ($0.16) | | | View | N/A | |
| 4/24/2012 | | $0.48 | $0.45 | | | View | N/A | |
| 2/7/2012 | | $0.55 | $0.57 | | | View | N/A | |
| 10/25/2011 | | $0.53 | $0.55 | | | View | N/A | |
| 7/26/2011 | | $0.54 | $0.54 | | | View | N/A | |
| 4/26/2011 | | $0.42 | $0.46 | | | View | N/A | |
| 2/8/2011 | | $0.48 | $0.50 | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Centene Corporation (NYSE:CNC)2017 EPS Consensus Estimate: $4.63
2018 EPS Consensus Estimate: $5.39
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 4 | $1.01 | $1.09 | $1.05 |
| Q2 2017 | 4 | $1.27 | $1.29 | $1.28 |
| Q3 2017 | 4 | $1.21 | $1.34 | $1.27 |
| Q4 2017 | 4 | $0.90 | $1.25 | $1.03 |
| Q1 2018 | 1 | $1.27 | $1.27 | $1.27 |
| Q2 2018 | 1 | $1.44 | $1.44 | $1.44 |
| Q3 2018 | 1 | $1.40 | $1.40 | $1.40 |
| Q4 2018 | 1 | $1.28 | $1.28 | $1.28 |
(Data provided by Zacks Investment Research)
Dividend History for Centene Corporation (NYSE:CNC)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Centene Corporation (NYSE:CNC)Insider Ownership Percentage: 3.00%
Institutional Ownership Percentage: 92.32%
Insider Trades by Quarter for Centene Corporation (NYSE:CNC)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 8/1/2017 | Christopher D. Bowers | EVP | Sell | 4,000 | $79.43 | $317,720.00 | |
| 7/27/2017 | Robert K. Ditmore | Director | Sell | 4,167 | $82.59 | $344,152.53 | |
| 7/6/2017 | Michael F. Neidorff | Chairman | Sell | 35,000 | $80.26 | $2,809,100.00 | |
| 6/12/2017 | Richard A. Gephardt | Director | Sell | 4,350 | $77.38 | $336,603.00 | |
| 6/2/2017 | Mark J. Brooks | SVP | Sell | 2,161 | $75.43 | $163,004.23 | |
| 6/2/2017 | Robert K. Ditmore | Director | Sell | 3,900 | $75.43 | $294,177.00 | |
| 5/1/2017 | Jesse N. Hunter | EVP | Sell | 5,000 | $74.40 | $372,000.00 | |
| 4/27/2017 | Christopher D. Bowers | EVP | Sell | 3,150 | $72.80 | $229,320.00 | |
| 4/27/2017 | Robert K. Ditmore | Director | Sell | 4,167 | $72.43 | $301,815.81 | |
| 3/27/2017 | Keith H. Williamson | EVP | Sell | 6,000 | $70.03 | $420,180.00 | |
| 3/13/2017 | Jeffrey A. Schwaneke | CFO | Sell | 2,000 | $68.52 | $137,040.00 | |
| 2/13/2017 | Jesse N. Hunter | EVP | Sell | 5,000 | $69.54 | $347,700.00 | |
| 12/1/2016 | Mark J. Brooks | SVP | Sell | 1,099 | $58.00 | $63,742.00 | |
| 11/7/2016 | Jesse N. Hunter | EVP | Sell | 5,000 | $65.00 | $325,000.00 | |
| 10/3/2016 | Carol Goldman | VP | Sell | 10,000 | $66.36 | $663,600.00 | |
| 10/3/2016 | Kenneth Rone Baldwin | EVP | Sell | 6,000 | $66.58 | $399,480.00 | |
| 9/7/2016 | Robert K. Ditmore | Director | Buy | 150 | $67.00 | $10,050.00 | |
| 7/1/2016 | Kenneth Rone Baldwin | EVP | Sell | 6,000 | $71.00 | $426,000.00 | |
| 6/29/2016 | Richard A. Gephardt | Director | Sell | 15,910 | $68.89 | $1,096,039.90 | |
| 6/24/2016 | Keith H. Williamson | EVP | Sell | 4,000 | $70.00 | $280,000.00 | |
| 6/6/2016 | Mark J Brooks | SVP | Sell | 3,914 | $65.01 | $254,449.14 | |
| 4/28/2016 | Jesse N Hunter | EVP | Sell | 10,000 | $65.17 | $651,700.00 | |
| 4/1/2016 | Kenneth Rone Baldwin | EVP | Sell | 6,000 | $60.87 | $365,220.00 | |
| 3/23/2016 | Carol Goldman | VP | Sell | 15,000 | $62.96 | $944,400.00 | |
| 1/4/2016 | Kenneth Rone Baldwin | EVP | Sell | 6,000 | $64.68 | $388,080.00 | |
| 12/22/2015 | Carol Goldman | VP | Sell | 25,000 | $65.19 | $1,629,750.00 | |
| 12/22/2015 | Jeffrey A Schwaneke | CAO | Sell | 2,000 | $65.09 | $130,180.00 | |
| 10/29/2015 | Carol Goldman | VP | Sell | 5,000 | $60.88 | $304,400.00 | |
| 7/1/2015 | Carol Goldman | VP | Sell | 5,000 | $81.20 | $406,000.00 | |
| 6/22/2015 | Keith H Williamson | EVP | Sell | 7,000 | $80.87 | $566,090.00 | |
| 6/18/2015 | William N Scheffel | CFO | Sell | 25,290 | $79.14 | $2,001,450.60 | |
| 5/4/2015 | Donald G Imholz | EVP | Sell | 5,000 | $65.08 | $325,400.00 | |
| 4/30/2015 | Carol Goldman | VP | Sell | 15,998 | $63.48 | $1,015,553.04 | |
| 4/30/2015 | Donald G Imholz | EVP | Sell | 5,000 | $63.72 | $318,600.00 | |
| 4/30/2015 | Robert K Ditmore | Director | Sell | 15,000 | $63.83 | $957,450.00 | |
| 4/6/2015 | Michael F Neidorff | CEO | Sell | 10,000 | $70.43 | $704,300.00 | |
| 4/1/2015 | Jesse N Hunter | EVP | Sell | 5,000 | $69.66 | $348,300.00 | |
| 3/19/2015 | Keith H Williamson | EVP | Sell | 5,000 | $70.18 | $350,900.00 | |
| 3/13/2015 | Tommy G Thompson | Director | Sell | 16,000 | $65.36 | $1,045,760.00 | |
| 3/9/2015 | Robert K Ditmore | Director | Sell | 15,000 | $63.19 | $947,850.00 | |
| 1/2/2015 | Carol Goldman | VP | Sell | 8,400 | $104.87 | $880,908.00 | |
| 1/2/2015 | Jesse N Hunter | EVP | Sell | 2,500 | $104.87 | $262,175.00 | |
| 12/16/2014 | Jeffrey A Schwaneke | CAO | Sell | 5,000 | $101.80 | $509,000.00 | |
| 10/1/2014 | Jesse N Hunter | EVP | Sell | 2,500 | $81.42 | $203,550.00 | |
| 9/22/2014 | Carol Goldman | VP | Sell | 12,500 | $81.85 | $1,023,125.00 | |
| 9/18/2014 | Donald G Imholz | EVP | Sell | 5,000 | $80.10 | $400,500.00 | |
| 9/15/2014 | Keith H Williamson | EVP | Sell | 4,000 | $77.48 | $309,920.00 | |
| 9/9/2014 | Jeffrey A Schwaneke | CAO | Sell | 1,000 | $79.51 | $79,510.00 | |
| 9/9/2014 | Jesse N Hunter | EVP | Sell | 5,000 | $79.35 | $396,750.00 | |
| 9/2/2014 | Donald G Imholz | EVP | Sell | 5,000 | $77.32 | $386,600.00 | |
| 8/28/2014 | Jeffrey A Schwaneke | CAO | Sell | 1,000 | $77.02 | $77,020.00 | |
| 5/12/2014 | Jason Harrold | EVP | Sell | 2,500 | $70.00 | $175,000.00 | |
| 4/2/2014 | Jason Harrold | EVP | Sell | 5,000 | $62.19 | $310,950.00 | |
| 3/31/2014 | Edmund Kroll | SVP | Sell | 5,000 | $62.00 | $310,000.00 | |
| 3/31/2014 | William Scheffel | CFO | Sell | 17,895 | $61.99 | $1,109,311.05 | |
| 2/6/2014 | Jesse Hunter | EVP | Sell | 5,000 | $61.66 | $308,300.00 | |
| 2/6/2014 | Michael Neidorff | CEO | Sell | 10,000 | $62.00 | $620,000.00 | |
| 12/17/2013 | Orlando Ayala | Director | Buy | 17,600 | $56.41 | $992,816.00 | |
| 7/25/2013 | Jeffrey A Schwaneke | CAO | Sell | 3,000 | $57.40 | $172,200.00 | |
| 7/25/2013 | Jesse N Hunter | EVP | Sell | 5,000 | $57.41 | $287,050.00 | |
| 6/13/2013 | Keith H Williamson | EVP | Sell | 5,800 | $50.25 | $291,450.00 | |
| 6/7/2013 | Donald G Imholz | EVP | Sell | 5,000 | $50.00 | $250,000.00 | |
| 6/3/2013 | Carol Goldman | VP | Sell | 10,000 | $49.28 | $492,800.00 | |
| 6/3/2013 | Jesse N Hunter | EVP | Sell | 6,000 | $48.28 | $289,680.00 | |
| 5/30/2013 | Jason M Harrold | EVP | Sell | 5,000 | $50.80 | $254,000.00 | |
| 5/30/2013 | Jeffrey A Schwaneke | CAO | Sell | 3,000 | $50.68 | $152,040.00 | |
| 5/30/2013 | William N Scheffel | CFO | Sell | 22,191 | $50.80 | $1,127,302.80 | |
| 5/10/2013 | Keith H Williamson | EVP | Sell | 3,000 | $50.00 | $150,000.00 | |
| 12/4/2012 | Carol Goldman | VP | Sell | 15,000 | $45.15 | $677,250.00 | |
| 12/4/2012 | Keith H Williamson | EVP | Sell | 9,000 | $45.10 | $405,900.00 | |
(Data available from 1/1/2013 forward)
Headline Trends for Centene Corporation (NYSE:CNC)
Latest Headlines for Centene Corporation (NYSE:CNC)
| Source: |
|
| Date | Headline |
|---|
 | Centene Corporation (CNC) PT Raised to $103.00 at Morgan Stanley
www.americanbankingnews.com - September 21 at 7:34 PM |
 | Centene: Cramer's Top Takeaways - TheStreet.com
www.thestreet.com - September 20 at 6:08 PM |
 | Insurance Industry Comes Out Against Graham-Cassidy Trumpcare Bill
finance.yahoo.com - September 20 at 6:08 PM |
| Cramer Remix: Why the Sprint & T-Mobile tie-up might be a done deal
finance.yahoo.com - September 19 at 10:27 PM |
| Centene: Cramer's Top Takeaways
finance.yahoo.com - September 19 at 10:27 PM |
 | Acquisition of New York health insurer will not affect Albany jobs - Albany Business Review
www.bizjournals.com - September 19 at 5:23 PM |
 | Notable Tuesday Option Activity: CNC, LMT, BBY - Nasdaq
www.nasdaq.com - September 19 at 5:23 PM |
| Coordinated Care Awarded Commendable Accreditation Status From NCQA
finance.yahoo.com - September 19 at 5:23 PM |
| 3 Healthcare Stocks to Buy on Renewed Obamacare Repeal Talks
finance.yahoo.com - September 19 at 5:23 PM |
| Wall Street Is Taking The Latest ObamaCare Repeal Push Seriously
finance.yahoo.com - September 19 at 5:23 PM |
| Healthcare Reform: Who Suffers?
finance.yahoo.com - September 19 at 5:23 PM |
| Featured Company News - Fidelis Care to be Acquired by Centene
finance.yahoo.com - September 15 at 5:47 PM |
| Featured Company News - Fidelis Care to be Acquired by Centene
finance.yahoo.com - September 15 at 5:47 PM |
| Anthem Changes Course, Will Offer Obamacare Plans In 63 Virginia Counties And Cities
finance.yahoo.com - September 15 at 5:47 PM |
| Anthem Changes Course, Will Offer Obamacare Plans In 63 Virginia Counties And Cities
finance.yahoo.com - September 15 at 5:47 PM |
| Zacks Investment Research Upgrades Centene Corporation (CNC) to "Buy"
www.americanbankingnews.com - September 15 at 1:46 PM |
| Centene Corporation (CNC) Forecasted to Post Q3 2018 Earnings of $1.40 Per Share
www.americanbankingnews.com - September 15 at 1:28 PM |
 | Centene Corp. (CNC) Soared To A New High After Buying Fidelis Care
www.rttnews.com - September 14 at 6:09 PM |
| Fidelis Care Buy Could Make Centene Less Likely Takeout Candidate
finance.yahoo.com - September 14 at 6:09 PM |
| Centene Corporation (CNC) Catches Eye: Stock Jumps 8%
finance.yahoo.com - September 14 at 6:09 PM |
| Centene Was the S&P 500’s Top Gainer on September 13
finance.yahoo.com - September 14 at 6:09 PM |
| Company News For Sep 14, 2017
finance.yahoo.com - September 14 at 6:09 PM |
| Centene Corporation's (CNC) "Buy" Rating Reiterated at Deutsche Bank AG
www.americanbankingnews.com - September 14 at 11:07 AM |
| Oppenheimer Holdings Equities Analysts Increase Earnings Estimates for Centene Corporation (CNC)
www.americanbankingnews.com - September 14 at 10:33 AM |
 | Centene Corp. agrees to buy Fidelis Care assets in New York state - MarketWatch
www.marketwatch.com - September 14 at 4:37 AM |
 | Premarket analyst action - healthcare - Seeking Alpha
seekingalpha.com - September 14 at 4:37 AM |
| Zacks: Analysts Anticipate Centene Corporation (CNC) Will Announce Earnings of $1.25 Per Share
www.americanbankingnews.com - September 14 at 2:20 AM |
| Centene Corporation (CNC) & Triple-S Management Corporation (GTS) Financial Comparison
www.americanbankingnews.com - September 14 at 12:26 AM |
 | Recent CNC News
www.bloomberg.com - September 13 at 6:33 PM |
| Centene Corp. (CNC) Has Jumped To A New High After Acquisition
www.nasdaq.com - September 13 at 6:33 PM |
| Centene's Fidelis Care Buyout to Expand Presence in New York
finance.yahoo.com - September 13 at 6:33 PM |
| Stocks to Watch: Nordstrom, Centene, American Airlines, Apple, Micron, Finish Line
finance.yahoo.com - September 13 at 6:33 PM |
| Centene Still Looking Bullish
finance.yahoo.com - September 13 at 6:33 PM |
| Centene Shares Spike on Fidelis Buy
finance.yahoo.com - September 13 at 6:33 PM |
| Coordinated Care Corp Indiana, Inc. -- Moody's affirms Centene's senior debt ratings at Ba2 after acquisition announcement
finance.yahoo.com - September 13 at 6:33 PM |
| Stock market edges higher to book another round of records
finance.yahoo.com - September 13 at 6:33 PM |
| Western Digital and Hologic skid; Centene, Nordstrom climb
finance.yahoo.com - September 13 at 6:33 PM |
| The Hot Stock: Centene Soars 8%
finance.yahoo.com - September 13 at 6:33 PM |
| Centene Corporation (CNC) PT Raised to $107.00
www.americanbankingnews.com - September 13 at 6:04 PM |
 | Centene Corp (CNC) Stock Surges on $3.7 Billion Fidelis Deal
investorplace.com - September 13 at 12:49 PM |
| Centene Corporation (CNC) Rating Reiterated by Cowen and Company
www.americanbankingnews.com - September 13 at 10:34 AM |
| Centene Corporation (CNC) Earns "Market Perform" Rating from Leerink Swann
www.americanbankingnews.com - September 13 at 9:52 AM |
 | Centene up sharply after $3.75B acquisition of Fidelis in NY
marketbeat.com - September 13 at 8:18 AM |
 | Centene (CNC) to Acquire Fidelis Care in $3.75B Deal
www.streetinsider.com - September 12 at 11:03 PM |
| Centene To Buy New York Health Plan For $3.7 Billion
finance.yahoo.com - September 12 at 11:03 PM |
| [$$] Centene Agrees to Buy Fidelis Care in $3.75 Billion Deal
finance.yahoo.com - September 12 at 11:03 PM |
 | Centene in a $3.75 billion deal for New York Medicaid leader Fidelis Care
www.cnbc.com - September 12 at 6:53 PM |
| Centene to acquire Fidelis Care for $3.75B; shares up 1% after hours
seekingalpha.com - September 12 at 6:32 PM |
| Centene Corp. (CNC) Is Climbing On Fidelis Care Deal
www.rttnews.com - September 12 at 5:58 PM |
| Centene Corp. (CNC) Is Climbing On Fidelis Care Deal
www.rttnews.com - September 12 at 5:58 PM |
Centene Corporation (CNC) Chart for Friday, September, 22, 2017
